2-Iodo-8,11-dimethoxy-4,7,12,12a-tetrahydro-5H-thieno[3',2':3,4]pyrido[1,2-b]isoquinoline

ID: ALA4161236

Chembl Id: CHEMBL4161236

PubChem CID: 145956462

Max Phase: Preclinical

Molecular Formula: C15H14INS

Molecular Weight: 367.25

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Ic1cc2c(s1)CCN1Cc3ccccc3CC21

Standard InChI:  InChI=1S/C15H14INS/c16-15-8-12-13-7-10-3-1-2-4-11(10)9-17(13)6-5-14(12)18-15/h1-4,8,13H,5-7,9H2

Standard InChI Key:  QLDXIRRCSZJNEQ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4161236

    ---

Associated Targets(Human)

PRKAG1 Tchem AMP-activated protein kinase (AMPK) alpha-1/beta-1/gamma-1 (619 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKAG2 Tchem AMPK alpha1/beta1/gamma2 (16 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKAB2 Tchem AMPK alpha1/beta2/gamma1 (35 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKAB2 Tchem AMP-activated protein kinase alpha-1/beta-2/gamma-3 (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKAA2 Tchem AMPK alpha2/beta1/gamma1 (210 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKAA2 Tchem AMP-activated protein kinase alpha-2/beta-1/gamma-3 (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKAA2 Tchem AMPK alpha2/beta2/gamma1 (80 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKAA2 Tchem AMP-activated protein kinase alpha-2/beta-2/gamma-2 (13 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

L6 (7924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hepatocyte (2621 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 367.25Molecular Weight (Monoisotopic): 366.9892AlogP: 4.01#Rotatable Bonds:
Polar Surface Area: 3.24Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 1HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.52CX LogP: 4.79CX LogD: 4.79
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.64Np Likeness Score: -0.21

References

1. Zhou S, Duan Y, Wang J, Zhang J, Sun H, Jiang H, Gu Z, Tong J, Li J, Li J, Liu H..  (2017)  Design, synthesis and biological evaluation of 4,7,12,12a-tetrahydro-5H-thieno[3',2':3,4]pyrido[1,2-b]isoquinolines as novel adenosine 5'-monophosphate-activated protein kinase (AMPK) indirect activators for the treatment of type 2 diabetes.,  140  [PMID:28987606] [10.1016/j.ejmech.2017.09.012]

Source